Nephrotoxicity from contrast media: attenuation with theophylline.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 7892462.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To determine if depression of creatinine clearance after administration of contrast medium may be prevented with theophylline. A nonionic, low-osmolality contrast medium (iopamidol) or an ionic, high-osmolality contrast medium (sodium diatrizoate) was administered to 93 patients. Before the examination, these patients were given theophylline or a placebo orally. There were also 30 patients who received an adenosine-uptake inhibitor (dipyridamole). Creatinine clearance and urinary adenosine levels were measured before and after angiography. Creatinine clearance decreased 18% +/- 4 in the placebo-iopamidol group but did not decrease in the theophylline group; urinary adenosine increased 67% +/- 7. Creatinine clearance decreased 42% +/- 5 in the placebo-sodium diatrizoate group and decreased 24% +/- 3 in the theophylline group; urinary adenosine increased 119% +/- 8. In the dipyridamole group in which iopamidol was given, urinary adenosine increased 96% +/- 7 and creatinine clearance decreased 37% +/- 5. Intrarenal adenosine can be implicated in the pathogenesis of hypertonic contrast medium nephrotoxicity.
Medical subject headings
- Adenosine
- Diatrizoate
- Dipyridamole
- Iopamidol
- Kidney
- Kidney Diseases
- Receptors, Purinergic P1
- Theophylline